Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

HDFC Pharma and Healthcare Fund · Regular ✕HDFC Business Cycle Fund · Regular ✕

Growth of ₹10,000

Basics

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseHDFCHDFC
NAV₹22.8170₹15.6450
NAV date20 Nov 202620 Nov 2026
History3.1 years4.0 years
Expense ratio2.1%2.1%
Stars★★★★★★★★★★
Growth Score93.9049.20

Returns

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
1 month+12.87%+7.59%
3 months+6.85%+1.66%
6 months+17.20%+11.28%
YTD+32.43%+6.77%
1 year+30.73%+4.91%
3 years (CAGR)+29.16%+10.77%
5 years (CAGR)——
10 years (CAGR)——
Since launch+30.28%+11.89%

Risk

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
Volatility15.8%15.5%
Downside volatility8.6%10.5%
Sharpe1.440.28
Sortino2.640.41
Calmar1.940.56
Return / risk1.850.70
Deepest fall−15.07%−19.40%
Days to recover133234
Below its high+0.00%+0.00%

Against benchmark

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
Alpha+6.36%−0.70%
Beta0.970.92
R²85.0%90.6%
Up capture106.7%92.4%
Down capture74.4%94.3%
Tracking error6.1%4.9%
Information ratio0.97−0.23
Treynor0.220.04

Consistency

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
Best 1-year+64.96%+38.26%
Middle 1-year+21.84%+5.55%
Worst 1-year+0.52%−7.13%
1-year periods with a loss0.0%14.6%
Middle 3-year+28.68%+11.45%
Positive months69.4%61.1%
Best day+3.19%+4.11%
Worst day−3.62%−6.25%
Worst 5% day−1.50%−1.53%
Positive days58.1%54.3%
NAVs a year247247

SIP of ₹10,000 a month

HDFC Pharma and Healthcare FundHDFC Business Cycle Fund
5-year XIRR——
5-year value——
3-year XIRR+26.26%+7.42%
1-year XIRR+39.84%+13.95%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth